We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+0.75%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$104B
AUM Growth
+$704M
Cap. Flow
-$915M
Cap. Flow %
-0.88%
Top 10 Hldgs %
14.25%
Holding
2,771
New
148
Increased
1,779
Reduced
566
Closed
77

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$191M
2
SCHW
Charles Schwab
SCHW
+$157M
3
PFE icon
Pfizer
PFE
+$139M
4
MMM icon
3M
MMM
+$131M
5
META icon
Meta Platforms (Facebook)
META
+$106M

Sector Composition

Rank Sector Weight
1 Healthcare 17.28%
2 Financials 14.69%
3 Technology 14.25%
4 Consumer Discretionary 9.55%
5 Industrials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCL
476
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
$38.1M 0.04%
938,416
+332,071
+55% +$13.9M
NBIX icon
477
Neurocrine Biosciences
NBIX
$16.6B
$38M 0.04%
796,643
-93,355
-10% -$3.96M
LNG icon
478
Cheniere Energy
LNG
$53.7B
$38M 0.04%
548,073
-6,441
-1% -$483K
AIZ icon
479
Assurant
AIZ
$14.8B
$37.9M 0.04%
565,482
+37,092
+7% +$2.39M
EMN icon
480
Eastman Chemical
EMN
$8.36B
$37.7M 0.04%
460,860
-9,631
-2% -$743K
NE
481
DELISTED
Noble Corporation
NE
$37.6M 0.04%
2,442,388
-638,155
-21% -$10.5M
HOG icon
482
Harley-Davidson
HOG
$2.77B
$37.5M 0.04%
665,937
-2,797
-0.4% -$160K
AGU
483
DELISTED
Agrium
AGU
$37.4M 0.04%
352,936
-9,575
-3% -$1.01M
SEE
484
DELISTED
Sealed Air
SEE
$37.4M 0.04%
727,071
+7,587
+1% +$365K
AES icon
485
AES
AES
$10.5B
$37.3M 0.04%
2,815,277
+6,951
+0.2% +$93.3K
EFX icon
486
Equifax
EFX
$20.6B
$37.3M 0.04%
384,043
-3,582
-0.9% -$349K
JBL icon
487
Jabil
JBL
$36.1B
$37.3M 0.04%
1,751,074
-939,144
-35% -$22.1M
TSCO icon
488
Tractor Supply
TSCO
$17.4B
$37.2M 0.04%
2,070,735
-3,730
-0.2% -$66.2K
JWN
489
DELISTED
Nordstrom
JWN
$36.9M 0.04%
495,541
+2,125
+0.4% +$162K
DISH
490
DELISTED
DISH Network Corp.
DISH
$36.7M 0.04%
541,448
-2,973
-0.5% -$208K
SNI
491
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$36.6M 0.04%
560,073
+71,552
+15% +$4.88M
IDTI
492
DELISTED
Integrated Device Technology I
IDTI
$36.5M 0.04%
1,683,076
+1,140,901
+210% +$24.6M
UDR icon
493
UDR
UDR
$12.4B
$36.4M 0.03%
1,137,214
+35,666
+3% +$1.17M
TSN icon
494
Tyson Foods
TSN
$20.5B
$35.9M 0.03%
842,993
+26,769
+3% +$1.1M
AVY icon
495
Avery Dennison
AVY
$13.3B
$35.8M 0.03%
587,815
-137,952
-19% -$8.02M
MHK icon
496
Mohawk Industries
MHK
$9.27B
$35.8M 0.03%
187,540
+3,131
+2% +$579K
CAM
497
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
$35.8M 0.03%
683,275
+24,132
+4% +$1.25M
ICPT
498
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$35.7M 0.03%
147,988
+19,463
+15% +$5.18M
NWL icon
499
Newell Brands
NWL
$2.67B
$35.7M 0.03%
868,477
-4,248
-0.5% -$170K
TIF
500
DELISTED
Tiffany & Co.
TIF
$35.6M 0.03%
388,003
-650
-0.2% -$58.2K

Similar funds

UBS AM's Q2 2015 Portfolio in Review

As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

  • UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
  • UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
  • UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
  • UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
  • UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
  • UBS AM opened 148 new positions and closed 77 in Q2 2015.
  • UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.

Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.